Veracyte (FRA:12V) ROE % Adjusted to Book Value : 0.67% (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Veracyte ROE % Adjusted to Book Value?

Veracyte's ROE % for the quarter that ended in Dec. 2024 was 1.79%. Veracyte's PB Ratio for the quarter that ended in Dec. 2024 was 2.66. Veracyte's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 0.67%.

Veracyte ROE % Adjusted to Book Value Historical Data

The historical data trend for Veracyte's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte ROE % Adjusted to Book Value Chart

Veracyte Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-1.53

-4.05

-2.20

-3.51

0.83

Veracyte Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-5.42	-0.47	1.35	2.34	0.67

Competitive Comparison of Veracyte's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Veracyte's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veracyte's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Veracyte's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Veracyte's ROE % Adjusted to Book Value falls into.

Veracyte ROE % Adjusted to Book Value Calculation

Veracyte's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.22%	/	2.66
	=	0.83%

Veracyte's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1.79%	/	2.66
	=	0.67%

Veracyte ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Veracyte's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Veracyte Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

VCYT:USA

Address

6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.veracyte.com

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.

Veracyte Headlines

No Headlines